This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Mukesh K Mahajan: Innovator in Interferon Gene Modulation
Introduction
Mukesh K Mahajan is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of stimulator of interferon genes (STING). His work has implications for therapeutic advancements in various medical conditions.
Latest Patents
Mukesh K Mahajan holds 1 patent for his invention titled "Modulators of stimulator of interferon genes (STING)." The patent discloses compounds having a specific formula, wherein various components are defined, including q, r, s, A, B, C, and R. These compounds may exist as tautomeric forms or as salts, particularly pharmaceutically acceptable salts.
Career Highlights
He is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to innovate and contribute to the field. His work focuses on developing new compounds that can enhance the understanding and treatment of diseases related to the immune system.
Collaborations
Mukesh has collaborated with notable colleagues, including David T Fosbenner and Todd L Graybill. These collaborations have fostered a productive environment for research and development in their respective fields.
Conclusion
Mukesh K Mahajan's contributions to the field of biotechnology, particularly through his patent on STING modulators, highlight his role as an innovator. His ongoing work at GlaxoSmithKline continues to pave the way for advancements in medical research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile